1. Home
  2. LIQT vs INTS Comparison

LIQT vs INTS Comparison

Compare LIQT & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LiqTech International Inc.

LIQT

LiqTech International Inc.

N/A

Current Price

$2.10

Market Cap

13.7M

Sector

Technology

ML Signal

N/A

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

N/A

Current Price

$5.21

Market Cap

13.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LIQT
INTS
Founded
2004
2012
Country
Denmark
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.7M
13.2M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
LIQT
INTS
Price
$2.10
$5.21
Analyst Decision
Strong Buy
Buy
Analyst Count
1
3
Target Price
$4.30
$38.00
AVG Volume (30 Days)
19.4K
27.8K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$42.12
N/A
Revenue Next Year
$63.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.22
$0.19
52 Week High
$3.35
$8.06

Technical Indicators

Market Signals
Indicator
LIQT
INTS
Relative Strength Index (RSI) 61.96 42.17
Support Level $2.19 $5.04
Resistance Level $2.56 $8.06
Average True Range (ATR) 0.23 0.20
MACD 0.01 -0.00
Stochastic Oscillator 75.44 37.51

Price Performance

Historical Comparison
LIQT
INTS

About LIQT LiqTech International Inc.

LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in businesses that are liquid filtration market and the silicon carbide ceramic membrane & diesel particulate filter (DPF) market. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and others. Its operating segment includes Water, Ceramics, and Plastics.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc . is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.

Share on Social Networks: